<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="1.2" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJMABHR</journal-id>
<journal-title-group><journal-title>International Journal of Medical and All Body Health Research</journal-title><abbrev-journal-title>IJMABHR</abbrev-journal-title></journal-title-group>
<issn pub-type="epub">2582-8940</issn>
<publisher><publisher-name>Anfo Publication House</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">298</article-id>
<article-id pub-id-type="doi">10.54660/IJMBHR.2022.3.1.48-62</article-id>
<title-group><article-title>Leveraging Algorithmic and Machine Learning Technologies for Breast Cancer Management in Sub-Saharan Africa</article-title></title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><name><surname>OPIA</surname><given-names>Frank Nwaogelenya</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author"><name><surname>MATTHEW</surname><given-names>Kayode A</given-names></name><xref ref-type="aff" rid="aff2"/></contrib>
<contrib contrib-type="author"><name><surname>MATTHEW</surname><given-names>Temitayo Femi</given-names></name><xref ref-type="aff" rid="aff3"/></contrib>
<aff id="aff1"><label>1</label>Accident and Emergency Department, Obafemi Awolowo University Teaching Hospital, Ile-Ife, Nigeria</aff>
<aff id="aff2"><label>2</label>Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, MO, United States</aff>
<aff id="aff3"><label>3</label>College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria</aff>
</contrib-group>
<pub-date publication-format="electronic" date-type="pub"><year>2022</year></pub-date>
<volume>3</volume>
<issue>4</issue>
<fpage>107</fpage>
<lpage>121</lpage>
<history>
<date date-type="received"><day>10</day><month>11</month><year>2022</year></date>
<date date-type="accepted"><day>12</day><month>12</month><year>2022</year></date>
</history>
<permissions><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-sa/4.0/?utm"><license-p>CC BY-NC-SA 4.0</license-p></license></permissions>
<self-uri xlink:href="https://www.allmedicaljournal.com/article/298/leveraging-algorithmic-and-machine-learning-technologies-for-breast-cancer-management-in-sub"/>
<self-uri content-type="pdf" xlink:href="https://www.allmedicaljournal.com/article/298/download"/>
<abstract><p>Due to delayed diagnosis, few treatment choices, and inadequate healthcare infrastructure, breast cancer continues to be a major worldwide health concern, with some of the greatest fatality rates occurring in Sub-Saharan Africa. By improving the treatment of breast cancer, machine learning (ML) and algorithmic technologies provide a game-changing chance to solve these issues. This study examines the current state of breast cancer in Sub-Saharan Africa, emphasizing the disease&apos;s startling prevalence and death rates as well as the structural and systemic obstacles to quality care, such as a lack of diagnostic resources, restricted access to treatment, and socioeconomic considerations. ML has a lot of potential in the medical field, especially in the areas of breast cancer early detection, diagnosis, and therapy planning. Medical image analysis and patient prediction have shown the effectiveness of machine learning models, including supervised, unsupervised, and reinforcement learning methods. However, implementing these technologies in Sub-Saharan Africa requires overcoming several barriers, including poor data availability, limited infrastructure, and a shortage of trained professionals. This paper highlights the importance of partnerships between governments, international organizations, and the tech industry in bridging these gaps. Recommendations include improving healthcare infrastructure, training healthcare workers, and developing region-specific ML models using local datasets to ensure cultural and contextual relevance. Addressing ethical concerns, such as data privacy and equitable access, is also emphasized to ensure the sustainable and inclusive adoption of these technologies. By leveraging ML and algorithmic technologies, Sub-Saharan Africa has the potential to significantly improve breast cancer outcomes, reduce mortality rates, and build a more robust and equitable healthcare system. Continued research, investment, and collaboration will be pivotal in achieving this vision.</p></abstract>
<kwd-group kwd-group-type="author"><kwd>Algorithm</kwd><kwd>Machine Learning</kwd><kwd>Technologies</kwd><kwd>Breast Cancer</kwd><kwd>Management</kwd><kwd>Sub-Saharan Africa</kwd></kwd-group>
</article-meta>
</front>
<back><ref-list><title>References</title>
<ref id="R1"><label>1</label><mixed-citation>Achilonu OJ, Singh E, Nimako G, Eijkemans RM, Musenge E. Rule‐based information extraction from free‐text pathology reports reveals trends in South African female breast cancer molecular subtypes and Ki67 expression. BioMed Res Int. 2022;2022(1):6157861.</mixed-citation></ref>
<ref id="R2"><label>2</label><mixed-citation>Adeoye J, Akinshipo A, Koohi-Moghadam M, Thomson P, Su YX. Construction of machine learning-based models for cancer outcomes in low and lower-middle income countries: A scoping review. Front Oncol. 2022;12:976168.</mixed-citation></ref>
<ref id="R3"><label>3</label><mixed-citation>Ahmad MAB. Mining health data for breast cancer diagnosis using machine learning [dissertation]. Canberra (AU): University of Canberra; 2013.</mixed-citation></ref>
<ref id="R4"><label>4</label><mixed-citation>Akuoko DE. Big data for better breast cancer treatment [master’s thesis]. Manchester (UK): The University of Manchester; 2020.</mixed-citation></ref>
<ref id="R5"><label>5</label><mixed-citation>Alli OI, Dada SA. Pharmacist-led smoking cessation programs: A comprehensive review of effectiveness, implementation models, and future directions. Int J Sci Technol Res Arch. 2022;3(2):297–304. Available from: https://doi.org/10.53771/ijstra.2022.3.2.0129</mixed-citation></ref>
<ref id="R6"><label>6</label><mixed-citation>Alli OI, Dada SA. Innovative models for tobacco dependency treatment: A review of advances in integrated care approaches in high-income healthcare systems. IRE J. 2021;5(6):273–282. ISSN: 2456-8880.</mixed-citation></ref>
<ref id="R7"><label>7</label><mixed-citation>Ampatzis C, Zervoudis S, Iatrakis G, Mastorakos G. Effect of oral contraceptives on bone mineral density. Acta Endocrinol (Buchar). 2022;18(3):355.</mixed-citation></ref>
<ref id="R8"><label>8</label><mixed-citation>Beaber EF, Buist DS, Barlow WE, Malone KE, Reed SD, Li CI. Recent oral contraceptive use by formulation and breast cancer risk among women 20 to 49 years of age. Cancer Res. 2014;74(15):4078–89.</mixed-citation></ref>
<ref id="R9"><label>9</label><mixed-citation>Benagiano G, Bastianelli C, Farris M. Contraception today. Ann N Y Acad Sci. 2006;1092(1):1–32.</mixed-citation></ref>
<ref id="R10"><label>10</label><mixed-citation>Boppart SA, Richards-Kortum R. Point-of-care and point-of-procedure optical imaging technologies for primary care and global health. Sci Transl Med. 2014;6(253):253rv2.</mixed-citation></ref>
<ref id="R11"><label>11</label><mixed-citation>Boyd NF, Melnichouk O, Martin LJ, Hislop G, Chiarelli AM, Yaffe MJ, Minkin S. Mammographic density, response to hormones, and breast cancer risk. J Clin International Journal of Medical and All Body Health Research www.allmedicaljournal.com Oncol. 2011;29(22):2985–92.</mixed-citation></ref>
<ref id="R12"><label>12</label><mixed-citation>Brooks JD, Nabi H, Andrulis IL, Antoniou AC, Chiquette J, Després P, Simard J. Personalized risk assessment for prevention and early detection of breast cancer: Integration and implementation (PERSPECTIVE I&amp;I). J Pers Med. 2021;11(6):511.</mixed-citation></ref>
<ref id="R13"><label>13</label><mixed-citation>Burke MM. Functional polymorphisms in the epidermal growth factor family genes and their relationship to the risk and severity of breast cancer [doctoral dissertation]. Manchester (UK): The University of Manchester; 2010.</mixed-citation></ref>
<ref id="R14"><label>14</label><mixed-citation>Burkman R, Bell C, Serfaty D. The evolution of combined oral contraception: Improving the risk-to-benefit ratio. Contraception. 2011;84(1):19–34.</mixed-citation></ref>
<ref id="R15"><label>15</label><mixed-citation>Cancino RS, Su Z, Mesa R, Tomlinson GE, Wang J. The impact of COVID-19 on cancer screening: Challenges and opportunities. JMIR Cancer. 2020;6(2):e21697.</mixed-citation></ref>
<ref id="R16"><label>16</label><mixed-citation>Chalfant JS, Hoyt AC. Breast density: Current knowledge, assessment methods, and clinical implications. J Breast Imaging. 2022;4(4):357–70.</mixed-citation></ref>
<ref id="R17"><label>17</label><mixed-citation>Christin-Maitre S. History of oral contraceptive drugs and their use worldwide. Best Pract Res Clin Endocrinol Metab. 2013;27(1):3–12.</mixed-citation></ref>
<ref id="R18"><label>18</label><mixed-citation>Chui M, Harryson M, Valley S, Manyika J, Roberts R. Notes from the AI frontier: Applying AI for social good [Internet]. 2018 [cited 2024 Feb 10]. Available from: https://www.mckinsey.com</mixed-citation></ref>
<ref id="R19"><label>19</label><mixed-citation>Cipriani S, Todisco T, Scavello I, Di Stasi V, Maseroli E, Vignozzi L. Obesity and hormonal contraception: An overview and a clinician’s practical guide. Eat Weight Disord Stud Anorexia Bulimia Obes. 2020;25:1129–40.</mixed-citation></ref>
<ref id="R20"><label>20</label><mixed-citation>Crouch BT, Gallagher J, Wang R, Duer J, Hall A, Soo MS, Ramanujam N. Exploiting heat shock protein expression to develop a non-invasive diagnostic tool for breast cancer. Sci Rep. 2019;9(1):3461.</mixed-citation></ref>
<ref id="R21"><label>21</label><mixed-citation>Dalene Skarping I. Mammographic density: A marker of treatment outcome in breast cancer? [doctoral dissertation]. Lund (SE): Lund University; 2020.</mixed-citation></ref>
<ref id="R22"><label>22</label><mixed-citation>Dannhauser A, Van den Berg VL. Prevalence of the known risk factors in women diagnosed with breast cancer at Queen II Hospital, Maseru [doctoral dissertation]. Bloemfontein (ZA): University of the Free State; 2011.</mixed-citation></ref>
<ref id="R23"><label>23</label><mixed-citation>De Hert M, Peuskens J, Sabbe T, Mitchell AJ, Stubbs B, Neven P, Detraux J. Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: A critical review. Acta Psychiatr Scand. 2016;133(1):5–22.</mixed-citation></ref>
<ref id="R24"><label>24</label><mixed-citation>De Leo V, Musacchio MC, Cappelli V, Piomboni P, Morgante G. Hormonal contraceptives: Pharmacology tailored to women&apos;s health. Hum Reprod Update. 2016;22(5):634–46.</mixed-citation></ref>
<ref id="R25"><label>25</label><mixed-citation>Del Pup L, Codacci-Pisanelli G, Peccatori F. Breast cancer risk of hormonal contraception: Counselling considering new evidence. Crit Rev Oncol Hematol. 2019;137:123–30.</mixed-citation></ref>
<ref id="R26"><label>26</label><mixed-citation>Dias JA, Fredrikson GN, Ericson U, Gullberg B, Hedblad B, Engström G, Wirfält E. Low-grade inflammation, oxidative stress and risk of invasive post-menopausal breast cancer: A nested case-control study within the Malmö diet and cancer study. Breast Cancer Res Treat. 2016;155(1):63–70.</mixed-citation></ref>
<ref id="R27"><label>27</label><mixed-citation>Dias JA, Fredrikson GN, Ericson U, Gullberg B, Hedblad B, Engström G, et al. Low-grade inflammation, oxidative stress and risk of invasive post-menopausal breast cancer—a nested case-control study from the Malmö Diet and Cancer Cohort. PLOS ONE. 2016;11(7):e0158959.</mixed-citation></ref>
<ref id="R28"><label>28</label><mixed-citation>Dragoman MV. The combined oral contraceptive pill— recent developments, risks and benefits. Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology. 2014;28(6):825-34.</mixed-citation></ref>
<ref id="R29"><label>29</label><mixed-citation>Elebro K. Androgen and Estrogen Receptors in Breast Cancer: Impact on Risk, Prognosis and Treatment Prediction [dissertation]. 2017.</mixed-citation></ref>
<ref id="R30"><label>30</label><mixed-citation>Elkefi S, Layeb SB. Artificial intelligence and operations research in a middle ground to support decision-making in healthcare systems in Africa. Africa Case Studies in Operations Research: A Closer Look into Applications and Algorithms. 2022;51-69.</mixed-citation></ref>
<ref id="R31"><label>31</label><mixed-citation>Feng MX, Hong JX, Wang Q, Fan YY, Yuan CT, Lei XH, et al. Dihydroartemisinin prevents breast cancer-induced osteolysis via inhibiting both breast cancer cells and osteoclasts. Scientific Reports. 2016;6(1):19074.</mixed-citation></ref>
<ref id="R32"><label>32</label><mixed-citation>Fischer A. Life Events, Perceived Stress and Breast Cancer Risk in the Hereditary Breast and Ovarian Cancer Study of Orange County, CA [dissertation]. UC Irvine; 2016.</mixed-citation></ref>
<ref id="R33"><label>33</label><mixed-citation>García Damián A. Disease Biomarkers in Metabolomics. 2020.</mixed-citation></ref>
<ref id="R34"><label>34</label><mixed-citation>Grindlay K, Burns B, Grossman D. Prescription requirements and over-the-counter access to oral contraceptives: a global review. Contraception. 2013;88(1):91-6.</mixed-citation></ref>
<ref id="R35"><label>35</label><mixed-citation>Gupta A, Anand A, Hasija Y. Recall-based machine learning approach for early detection of cervical cancer. In: 2021 6th International Conference for Convergence in Technology (I2CT). IEEE; 2021. p. 1-5.</mixed-citation></ref>
<ref id="R36"><label>36</label><mixed-citation>Hager E, Chen J, Zhao L. Minireview: parabens exposure and breast cancer. International Journal of Environmental Research and Public Health. 2022;19(3):1873.</mixed-citation></ref>
<ref id="R37"><label>37</label><mixed-citation>Hampson E. A brief guide to the menstrual cycle and oral contraceptive use for researchers in behavioral endocrinology. Hormones and Behavior. 2020;119:104655.</mixed-citation></ref>
<ref id="R38"><label>38</label><mixed-citation>Haney K, Tandon P, Divi R, Ossandon MR, Baker H, Pearlman PC. The role of affordable, point-of-care technologies for cancer care in low-and middle-income countries: a review and commentary. IEEE Journal of Translational Engineering in Health and Medicine. 2017;5:1-14.</mixed-citation></ref>
<ref id="R39"><label>39</label><mixed-citation>Harvey JA, Bovbjerg VE. Quantitative assessment of mammographic breast density: relationship with breast cancer risk. Radiology. 2004;230(1):29-41.</mixed-citation></ref>
<ref id="R40"><label>40</label><mixed-citation>Harz M. Complexity Reduction in Image-Based Breast Cancer Care [dissertation]. Staats -und Universitätsbibliothek Bremen; 2014.</mixed-citation></ref>
<ref id="R41"><label>41</label><mixed-citation>Hasyim NA. MAGEB2 Antibody as Potential Diagnostic and Predictive Tool in the Progression of Oral Cancer [master’s thesis]. University of Malaya (Malaysia); 2020.</mixed-citation></ref>
<ref id="R42"><label>42</label><mixed-citation>Helland T. Tamoxifen in the Treatment of Luminal Breast Cancer: Implications of Active Metabolites on Gene Expression, Side Effects and Clinical Outcome. 2019.</mixed-citation></ref>
<ref id="R43"><label>43</label><mixed-citation>Ikerionwu C, Ugwuishiwu C, Okpala I, James I, Okoronkwo M, Nnadi C, et al. Application of machine and deep learning algorithms in optical microscopic International Journal of Medical and All Body Health Research www.allmedicaljournal.com detection of Plasmodium: A malaria diagnostic tool for the future. Photodiagnosis and Photodynamic Therapy. 2022;40:103198.</mixed-citation></ref>
<ref id="R44"><label>44</label><mixed-citation>Kanadys W, Barańska A, Malm M, Błaszczuk A, Polz-Dacewicz M, Janiszewska M, et al. Use of oral contraceptives as a potential risk factor for breast cancer: a systematic review and meta-analysis of case-control studies up to 2010. International Journal of Environmental Research and Public Health. 2021;18(9):4638.</mixed-citation></ref>
<ref id="R45"><label>45</label><mixed-citation>Kennedy CE, Yeh PT, Gonsalves L, Jafri H, Gaffield ME, Kiarie J, et al. Should oral contraceptive pills be available without a prescription? A systematic review of over-the-counter and pharmacy access availability. BMJ Global Health. 2019;4(3):e001402.</mixed-citation></ref>
<ref id="R46"><label>46</label><mixed-citation>Kimera R, Kaggwa F, Mwavu R, Mugonza R, Tumuhimbise W, Munguci G, et al. Mbarara University of Science and Technology (MUST). Leveraging Data Science for Global Health. 2020;329.</mixed-citation></ref>
<ref id="R47"><label>47</label><mixed-citation>Kimera R, Kaggwa F, Mwavu R, Mugonza R, Tumuhimbise W, Munguci G, et al. An overview of data science innovations, challenges and limitations towards real-world implementations in global health. 2020.</mixed-citation></ref>
<ref id="R48"><label>48</label><mixed-citation>Kiyasseh D, Zhu T, Clifton D. The promise of clinical decision support systems targeting low-resource settings. IEEE Reviews in Biomedical Engineering. 2020;15:354-71.</mixed-citation></ref>
<ref id="R49"><label>49</label><mixed-citation>Kumar N. Application of Machine Learning for Breast Cancer Diagnosis [dissertation]. MNIT Jaipur; 2019.</mixed-citation></ref>
<ref id="R50"><label>50</label><mixed-citation>Kurta ML. Ovarian Cancer Epidemiology: Risk, Diagnosis, and Prognosis [dissertation]. University of Pittsburgh; 2013.</mixed-citation></ref>
<ref id="R51"><label>51</label><mixed-citation>Li MX, Sun XM, Cheng WG, Ruan HJ, Liu K, Chen P, et al. Using a machine learning approach to identify key prognostic molecules for esophageal squamous cell carcinoma. BMC Cancer. 2021;21:1-11.</mixed-citation></ref>
<ref id="R52"><label>52</label><mixed-citation>Liu ZYC, Chamberlin AJ, Tallam K, Jones IJ, Lamore LL, Bauer J, et al. Deep learning segmentation of satellite imagery identifies aquatic vegetation associated with snail intermediate hosts of schistosomiasis in Senegal, Africa. Remote Sensing. 2022;14(6):1345.</mixed-citation></ref>
<ref id="R53"><label>53</label><mixed-citation>Mahboobnia K, Pirro M, Marini E, Grignani F, Bezsonov EE, Jamialahmadi T, et al. PCSK9 and cancer: Rethinking the link. Biomedicine &amp; Pharmacotherapy. 2021;140:111758.</mixed-citation></ref>
<ref id="R54"><label>54</label><mixed-citation>Marchbanks PA, Curtis KM, Mandel MG, Wilson HG, Jeng G, Folger SG, et al. Oral contraceptive formulation and risk of breast cancer. Contraception. 2012;85(4):342-50.</mixed-citation></ref>
<ref id="R55"><label>55</label><mixed-citation>Masarwah A. Mammographic breast density, tumour characteristics and the expression of hyaluronan as prognostic surrogate markers for breast cancer [dissertation]. Itä-Suomen yliopisto; 2016.</mixed-citation></ref>
<ref id="R56"><label>56</label><mixed-citation>Mathew A, Doorenbos AZ, Li H, Jang MK, Park CG, Bronas UG. Allostatic load in cancer: a systematic review and mini meta-analysis. Biol Res Nurs. 2021;23(3):341-61.</mixed-citation></ref>
<ref id="R57"><label>57</label><mixed-citation>Monteiro AC, Leal AC, Gonçalves-Silva T, Mercadante ACT, Kestelman F, Chaves SB, et al. T cells induce pre-metastatic osteolytic disease and help bone metastases establishment in a mouse model of metastatic breast cancer. PLoS One. 2013;8(7):e68171.</mixed-citation></ref>
<ref id="R58"><label>58</label><mixed-citation>Moore JX, Han Y, Appleton C, Colditz G, Toriola AT. Determinants of mammographic breast density by race among a large screening population. JNCI Cancer Spectr. 2020;4(2):pkaa010.</mixed-citation></ref>
<ref id="R59"><label>59</label><mixed-citation>Mørch LS, Skovlund CW, Hannaford PC, Iversen L, Fielding S, Lidegaard Ø. Contemporary hormonal contraception and the risk of breast cancer. N Engl J Med. 2017;377(23):2228-39.</mixed-citation></ref>
<ref id="R60"><label>60</label><mixed-citation>Moyo D. Breast and cervical cancer prediction using supervised machine learning algorithms. 2022.</mixed-citation></ref>
<ref id="R61"><label>61</label><mixed-citation>Mu T. Design of machine learning algorithms with applications to breast cancer detection [dissertation]. University of Liverpool; 2008.</mixed-citation></ref>
<ref id="R62"><label>62</label><mixed-citation>Mulukuntla S, Gaddam M. Overcoming barriers to equity in healthcare access: innovative solutions through technology. EPH-Int J Med Health Sci. 2017;3(1):51-60.</mixed-citation></ref>
<ref id="R63"><label>63</label><mixed-citation>National Academies of Sciences, Engineering, and Medicine. Optimizing the patient journey by leveraging advances in health care. In: Crossing the Global Quality Chasm: Improving Health Care Worldwide. National Academies Press (US); 2018.</mixed-citation></ref>
<ref id="R64"><label>64</label><mixed-citation>Neeman E, Lyon L, Sun H, Conell C, Reed M, Kumar D, et al. Future of teleoncology: trends and disparities in telehealth and secure message utilization in the COVID-19 era. JCO Clin Cancer Inform. 2022;6:e2100160.</mixed-citation></ref>
<ref id="R65"><label>65</label><mixed-citation>Ngwa W, Olver I, Schmeler KM. The use of health-related technology to reduce the gap between developed and undeveloped regions around the globe. Am Soc Clin Oncol Educ Book. 2020;40:227-36.</mixed-citation></ref>
<ref id="R66"><label>66</label><mixed-citation>Oliveira B, Jones E, Glavin M, O’Halloran M. Towards improved breast cancer diagnosis using microwave technology and machine learning [dissertation]. Ph.D. thesis, NUI Galway; 2018.</mixed-citation></ref>
<ref id="R67"><label>67</label><mixed-citation>Oskar S. Exposure to phthalates during critical windows of susceptibility and breast tissue composition: implications for breast cancer risk. Columbia University; 2021.</mixed-citation></ref>
<ref id="R68"><label>68</label><mixed-citation>Pai V, Baker H, Lash TB. The National Institutes of Health Affordable Cancer Technologies Program: improving access to resource-appropriate technologies for cancer detection, diagnosis, monitoring, and treatment in low- and middle-income countries. 2016.</mixed-citation></ref>
<ref id="R69"><label>69</label><mixed-citation>Pan L, Feng Z, Peng S. A review of machine learning approaches, challenges and prospects for computational tumor pathology. arXiv preprint arXiv:2206.01728. 2022.</mixed-citation></ref>
<ref id="R70"><label>70</label><mixed-citation>Pareek PK, Surendhar SP, Prasad R, Ramkumar G, Dixit E, Subbiah R, et al. [Retracted] Predicting the spread of vessels in initial-stage cervical cancer through radiomics strategy based on deep learning approach. Adv Mater Sci Eng. 2022;2022(1):1008652.</mixed-citation></ref>
<ref id="R71"><label>71</label><mixed-citation>Passey A. Epigenetic biomarkers for clinical outcomes and mechanisms driving emergence of drug resistance in ovarian cancer [dissertation]. Imperial College London; 2017.</mixed-citation></ref>
<ref id="R72"><label>72</label><mixed-citation>Patel MI, Ferguson JM, Castro E, Pereira-Estremera CD, Armaiz-Peña GN, Duron Y, et al. Racial and ethnic disparities in cancer care during the COVID-19 pandemic. JAMA Netw Open. 2022;5(7):e2222009.</mixed-citation></ref>
<ref id="R73"><label>73</label><mixed-citation>Quinn J. Evaluation of the role of autophagy in ovarian cancer chemoresistance. 2020.</mixed-citation></ref>
<ref id="R74"><label>74</label><mixed-citation>Rajaneesh N. Risk factors in breast cancer: work on preventing recurrence. Notion Press; 2021.</mixed-citation></ref>
<ref id="R75"><label>75</label><mixed-citation>Ramanujam N, Crouch B. Democratizing cancer diagnostics and therapeutics through precision medicine. Technol Innov. 2019;20(4):399-413. International Journal of Medical and All Body Health Research www.allmedicaljournal.com</mixed-citation></ref>
<ref id="R76"><label>76</label><mixed-citation>Ramón y Cajal T, Chirivella I, Miranda J, Teule A, Izquierdo Á, Balmaña J, et al. Mammographic density and breast cancer in women from high-risk families. Breast Cancer Res. 2015;17:1-11.</mixed-citation></ref>
<ref id="R77"><label>77</label><mixed-citation>Renner RM, Jensen JT. Progestin‐only oral contraceptive pills. Contraception. 2011;40-56.</mixed-citation></ref>
<ref id="R78"><label>78</label><mixed-citation>Riondino S, Ferroni P, Zanzotto FM, Roselli M, Guadagni F. Predicting VTE in cancer patients: candidate biomarkers and risk assessment models. Cancers. 2019;11(1):95.</mixed-citation></ref>
<ref id="R79"><label>79</label><mixed-citation>Saleh M, Naik G, Mwirigi A, Shaikh AJ, Sayani S, Ghesani M, et al. Bridging the gap in training and clinical practice in Sub-Saharan Africa. Curr Breast Cancer Rep. 2019;11:158-69.</mixed-citation></ref>
<ref id="R80"><label>80</label><mixed-citation>Samson ME. Progesterone-only oral contraceptive pill, breast cancer, heart disease, and stroke. 2016.</mixed-citation></ref>
<ref id="R81"><label>81</label><mixed-citation>Santen RJ, Allred DC, Ardoin SP, Archer DF, Boyd N, Braunstein GD, et al. Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab. 2010;95(7_supplement_1):s1-66.</mixed-citation></ref>
<ref id="R82"><label>82</label><mixed-citation>Santosh KC, Gaur L. Artificial intelligence and machine learning in public healthcare: opportunities and societal impact. Springer Nature; 2022.</mixed-citation></ref>
<ref id="R83"><label>83</label><mixed-citation>Seo BR, Bhardwaj P, Choi S, Gonzalez J, Andresen Eguiluz RC, Wang K, et al. Obesity-dependent changes in interstitial ECM mechanics promote breast tumorigenesis. Sci Transl Med. 2015;7(301):301ra130.</mixed-citation></ref>
<ref id="R84"><label>84</label><mixed-citation>Shah D, Patil M, National PCOS Working Group. Consensus statement on the use of oral contraceptive pills in polycystic ovarian syndrome women in India. J Hum Reprod Sci 2018;11(2):96-118.</mixed-citation></ref>
<ref id="R85"><label>85</label><mixed-citation>Shaikh K, Krishnan S, Thanki RM. Artificial intelligence in breast cancer early detection and diagnosis. Cham: Springer; 2021. p. 209-49.</mixed-citation></ref>
<ref id="R86"><label>86</label><mixed-citation>Shubbar S. Ultrasound medical imaging systems using telemedicine and blockchain for remote monitoring of responses to neoadjuvant chemotherapy in women’s breast cancer: concept and implementation [Master&apos;s thesis]. Kent State Univ; 2017.</mixed-citation></ref>
<ref id="R87"><label>87</label><mixed-citation>Shukla AK, Jamwal R, Bala K. Adverse effect of combined oral contraceptive pills. Asian J Pharm Clin Res 2017;10:17-21.</mixed-citation></ref>
<ref id="R88"><label>88</label><mixed-citation>Shukla AK, Jamwal R, Bala K. Adverse effect of combined oral contraceptive pills. Asian J Pharm Clin Res 2017;10:17-21.</mixed-citation></ref>
<ref id="R89"><label>89</label><mixed-citation>Sitruk-Ware R, Nath A, Mishell DR Jr. Contraception technology: past, present and future. Contraception 2013;87(3):319-30.</mixed-citation></ref>
<ref id="R90"><label>90</label><mixed-citation>Stanczyk FZ, Archer DF, Bhavnani BR. Ethinyl estradiol and 17β-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics, and risk assessment. Contraception 2013;87(6):706-27.</mixed-citation></ref>
<ref id="R91"><label>91</label><mixed-citation>Tenti S, Correale P, Cheleschi S, Fioravanti A, Pirtoli L. Aromatase inhibitors—induced musculoskeletal disorders: current knowledge on clinical and molecular aspects. Int J Mol Sci 2020;21(16):5625.</mixed-citation></ref>
<ref id="R92"><label>92</label><mixed-citation>Tesic V, Kolaric B, Znaor A, Kuna SK, Brkljacic B. Mammographic density and estimation of breast cancer risk in intermediate risk population. Breast J 2013;19(1):71-8.</mixed-citation></ref>
<ref id="R93"><label>93</label><mixed-citation>Thomford NE, Bope CD, Agamah FE, Dzobo K, Owusu Ateko R, Chimusa E, et al. Implementing artificial intelligence and digital health in resource-limited settings? Top 10 lessons we learned in congenital heart defects and cardiology. Omics 2020;24(5):264-77.</mixed-citation></ref>
<ref id="R94"><label>94</label><mixed-citation>Thompson PA, Preece C, Stopeck AT. Breast cancer prevention. In: Fundamentals of cancer prevention. Springer; 2019. p. 543-606.</mixed-citation></ref>
<ref id="R95"><label>95</label><mixed-citation>Upadhya KK, Santelli JS, Raine-Bennett TR, Kottke MJ, Grossman D. Over-the-counter access to oral contraceptives for adolescents. J Adolesc Health 2017;60(6):634-40.</mixed-citation></ref>
<ref id="R96"><label>96</label><mixed-citation>Van der Westhuizen E, Van der Merwe E. The safety and efficacy of low-dose oral contraceptives: CPD article. S Afr Fam Pract 2011;53(5):403-11.</mixed-citation></ref>
<ref id="R97"><label>97</label><mixed-citation>Verma N, Cwiak C, Kaunitz AM. Hormonal contraception: systemic estrogen and progestin preparations. Clin Obstet Gynecol 2021;64(4):721-38.</mixed-citation></ref>
<ref id="R98"><label>98</label><mixed-citation>Waljee AK, Weinheimer-Haus EM, Abubakar A, Ngugi AK, Siwo GH, Kwakye G, et al. Artificial intelligence and machine learning for early detection and diagnosis of colorectal cancer in sub-Saharan Africa. Gut 2022;71(7):1259-65.</mixed-citation></ref>
<ref id="R99"><label>99</label><mixed-citation>Westbrook K, Stearns V. Pharmacogenomics of breast cancer therapy: an update. Pharmacol Ther 2013;139(1):1-11.</mixed-citation></ref>
<ref id="R100"><label>100</label><mixed-citation>White A. Multiple sources of PAH exposure, DNA methylation and breast cancer. [Unpublished thesis]. 2015.</mixed-citation></ref>
<ref id="R101"><label>101</label><mixed-citation>White ND. Hormonal contraception and breast cancer risk. Am J Lifestyle Med 2018;12(3):224-6.</mixed-citation></ref>
<ref id="R102"><label>102</label><mixed-citation>Wiegratz I, Kuhl H. Long-cycle treatment with oral contraceptives. Drugs 2004;64:2447-62.</mixed-citation></ref>
<ref id="R103"><label>103</label><mixed-citation>Wong CS, Lim GH, Gao F, Jakes RW, Offman J, Chia KS, et al. Mammographic density and its interaction with other breast cancer risk factors in an Asian population. Br J Cancer 2011;104(5):871-4.</mixed-citation></ref>
<ref id="R104"><label>104</label><mixed-citation>Wu L, Janagam DR, Mandrell TD, Johnson JR, Lowe TL. Long-acting injectable hormonal dosage forms for contraception. Pharm Res 2015;32:2180-91.</mixed-citation></ref>
<ref id="R105"><label>105</label><mixed-citation>Yaghjyan L, Mahoney MC, Succop P, Wones R, Buckholz J, Pinney S. Relationship between breast cancer risk factors and mammographic breast density in the Fernald Community Cohort. Br J Cancer 2012;106(5):996-1003.</mixed-citation></ref>
<ref id="R106"><label>106</label><mixed-citation>Yaghjyan L, Smotherman C, Heine J, Colditz GA, Rosner B, Tamimi RM. Associations of oral contraceptives with mammographic breast density in premenopausal women. Cancer Epidemiol Biomarkers Prev 2022;31(2):436-42.</mixed-citation></ref>
<ref id="R107"><label>107</label><mixed-citation>Yang G, Nowsheen S, Aziz K, Georgakilas AG. Toxicity and adverse effects of Tamoxifen and other anti-estrogen drugs. Pharmacol Ther 2013;139(3):392-404.</mixed-citation></ref>
</ref-list></back>
</article>